Tribal Rides/Xinda Announces Kick-Off of Beta Program
Development progress milestone for transportation technology company MISSION VIEJO, CA / ACCESSWIRE / March 1,…
Development progress milestone for transportation technology company MISSION VIEJO, CA / ACCESSWIRE / March 1,…
AUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a…
NEW YORK, NY / ACCESSWIRE / March 1, 2021 / Zedge, Inc., (NYSE American:ZDGE) will…
1st Layer 2 Lending protocol to list staked derivative assets as collaterals GURUGRAM, INDIA /…
ROCKVILLE, MD / ACCESSWIRE / March 1, 2021 / Fifty years ago, a small group…
Consumers can purchase SHRU through SHRUCOIN.com or visit SHRUCOINPAY.com to create an account through Minerco’s…
CHINO, CA / ACCESSWIRE / March 1, 2021 / Great things are in the works…
SANTA CLARA, CA / ACCESSWIRE / March 1, 2021 / SPI Energy Co., Ltd., (NASDAQ:SPI)…
VANCOUVER, BC / ACCESSWIRE / March 1, 2021 / EMPOWER CLINICS INC. (CBDT:CSE)(8EC:Frankfurt)(EPWCF:OTCQB) (“Empower” or…
TORONTO, ON / ACCESSWIRE / March 1, 2021 / PJX Resources Inc. (“PJX” or “the…
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
COLLABORATION WILL LEVERAGE THE NURTURE PATIENT BIOBANK AND EVOTEC’S MULTI-OMICS PLATFORMS PANHUNTER AND PANOMICS EVOTEC…
Appointment of Financial Advisor LONDON, UK / ACCESSWIRE / March 1, 2021 / World High…
Exercise of Warrants, Issue of Shares and Total Voting Rights LONDON, UK / ACCESSWIRE /…
Directors Share Dealings & Grant of Awards under Deferred Bonus Plan LONDON, ENGLAND / ACCESSWIRE…
Actus launches new capabilities designed to reduce remote management pressures caused by COVID-19 79% of…
Press Release 1 March 2021 Immunicum AB (publ) Announces Appointment of Jeroen Rovers as Chief…
Montrouge, France, March 1, 2020 DBV Technologies to Report Full Year 2020 Financial Results on…
LONDON, March 01, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (“OKYO” or the “Company”) today…
LONDON and RALEIGH, N.C., March 01, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…